Introduction
============

A 34--year-old male presented for general examination on day 49 of a 50-day self-imposed fast, seeking approval to continue his fasting behavior. During this period, the patient reported only consuming water, tea, coffee (with no milk or sugar), and a daily multivitamin tablet (Centrum Performance; Pfizer).

Patient history prior to fasting behavior revealed a family history of obesity and the presence of pathologies related to body mass. Personal history involved an oscillating mass between 85 and 134 kg over a 10-year period. At the start of fasting, the patient reported body mass as 96.8 kg, and 29.2% body fat, as recorded by a personal bioelectrical impedance device. History following the onset of fasting behavior was unremarkable, but included severe abdominal cramps between days 7 and 21 of fasting, development and frequent occurrence of vasovagal syncope on transition from sitting to standing, and the near-cessation of fecal movement. Eructation frequency was significantly increased. Self-reported physical activity and mobility was reduced, but not prevented; this participant was not bedridden. Substantial water and coffee intake was noted (8--12 cups of coffee daily and 2--3 bottles of water daily). As expected, body mass loss during fasting was severe and noticeable ([Fig. 1](#f1-ccrep-9-2016-067){ref-type="fig"}).

Initial examination showed maintenance of motor and cranial nerve function. Resting metabolic rate (30 minutes by indirect calorimetry) was 1626 kcal day^−1^. During the 30-minute rest period, ECG and blood pressure were monitored. Resting ECG appeared morphologically normal, patient was bradycardic (52 bpm) and notably hypertensive (150/78 mmHg). Body composition was measured by whole-body air displacement plethysmography (Bod Pod) as 19.8% body fat, while height was 180.9 cm and mass was 75.4 kg, with a BMI of 23.5 kg m^−1^, all recorded on calibrated laboratory devices. Sum of four skinfolds[@b1-ccrep-9-2016-067] was 30.0 mm, approximately half of that of a reference population of similarly aged males (62 ± 25 mm, aged 30--39). It was visually noted that subcutaneous fat in the abdominal region was still present, despite severe losses in the peripheral limbs, protruding ribs, and lack of prominent chest and shoulder musculature. A grade 1/2 panniculus resulting from rapid abdominal adipose loss was present ([Fig. 2](#f2-ccrep-9-2016-067){ref-type="fig"}). During a six-minute walk test, this individual covered 342 m, which was below expected performance for a healthy male adult.[@b2-ccrep-9-2016-067] A mild scoliosis was observed while walking; however, it is unclear if this is related to fasting.

Venous blood was taken for serum markers of metabolism, liver, and renal function. Results are given in [Table 1](#t1-ccrep-9-2016-067){ref-type="table"}. Noteworthy findings include plasma glucose of 3.1 mmol L^−1^ and alkaline phosphatase of 36 U L^−1^. Total bilirubin was 19 µmol L^−1^, direct bilirubin was 7 µmol L^−1^. Uric acid was 620 µmol L^−1^.

Urine was straw colored, lacked sediment, and was noticeably sweet in aroma. Rapid dipstick analysis (Multistix 2161; Siemens) was negative for blood glucose, contained trace proteins, and indicated urine pH of below 5. Urine was highly ketonuric (\>16 mmol L^−1^).

One Month Past Breaking of Fast
===============================

One month following initial presentation, the patient returned for follow-up examination during which body composition, resting metabolic rate, urine, and venous blood were recorded. Resumption of feeding initially involved liquids such as vege table soups, with the resumption of solid foods three days following breaking of fast. Days 3--5 involved one solid meal per day, with 2--3 solid meals during days 5--7, and the resumption of three solid food meals per day for 7 days following breaking of fast. In the following 23 days, diet was reported to be of caffeine and alcohol free, low carbohydrate (a piece of bread every 1--3 days), and high servings of fruit and vegetables. Self-estimation of diet by volume was 20% animal protein (chicken and fish) and 80% fruit or vegetables; validated, quantifiable measures of intake and caloric content are not available. Heart rate remained bradycardic at rest (48 bpm), and blood pressure was notably reduced (132/78). Metabolic rate was reduced (1413 kcal day^−1^), and body composition was unchanged (75.0 kg; BMI, 23.4 kg m^−1^; 16.1% fat mass). Urinary ketones were reduced, but not removed. Normal fecal movements were reported to begin seven days following resumption of feeding. Blood biochemistry returned to within normal range, with the exception of direct bilirubin ([Table 1](#t1-ccrep-9-2016-067){ref-type="table"}). The six-minute walk test was repeated, and the patient covered 401 m.

Discussion
==========

Clinical examinations and research models reporting such severe starvation are absent in modern literature. Clear ethical barriers preclude structured research into the physiology of such stimuli. It is noteworthy, therefore, in this case study that moderate physical function appears maintained at day 49, as assessed by general observation and results of the six-minute walk test. Frommel et al.[@b3-ccrep-9-2016-067] suggested that fasting in healthy lean individuals was well tolerated until 18% of body mass was lost; the patient reported here lost 20.7% of body mass without substantial loss of function. One prior report of long-term fasting in obese individuals for 30--40 days demonstrated body mass losses between 10.6% and 20.5%, but does not report on function of individuals.[@b4-ccrep-9-2016-067] It seems self-apparent and supported by this limited evidence, such that the starting mass is a key variable in survival of extreme fasting, and not the amount of loss. This patient started fasting while obese and ended his fast when anthropometric variables were within the targeted ranges for the general population. Indeed, among the few (nonpublished) examples of complete fasting and mortality,[@b5-ccrep-9-2016-067] patients were frail between 30 and 50 days, and death was noted to occur between days 43 and 70, which this case study has reached without obvious or significant frailty occurring. These findings were reported in nonoverweight individuals.

Current World Medical Association guidelines prioritize autonomy, recommending nonintervention in fasting to the point of harm and/or death, if the patient makes a written informed statement of intent.[@b5-ccrep-9-2016-067] Lack of research into this field precludes evidence-based decision-making or advice. In the limited light of this case study and historic data of fasting in obesity,[@b4-ccrep-9-2016-067] it is tempting to suggest that guidelines to physicians for advice to the fasting individual reflect body mass, and specifically mass of adiposity at start of fasting behavior. Survival in starvation is ultimately governed by physics, the calories available to maintain metabolic function. Availability of adipose tissue for metabolic usage may thus delay the catastrophic degradation of muscular protein, increasing survival time.

That said, small animal models reveal organ-specific effects of starvation, with loss of liver and gut size and function noted after only four to six days.[@b6-ccrep-9-2016-067] Functional damage to digestive organs cannot be ruled out, and indeed, the elevated direct bilirubin is suggestive of reduced liver filtration. Of concern, direct bilirubin remained elevated 30 days post breaking of fast. Elevated uric acid is likely due to reduced kidney filtration, as has been reported in caloric restriction previously.[@b7-ccrep-9-2016-067]

Further, hypertension was an unexpected finding. This finding is counter to one of the few published examinations of cardiology in severe starvation, where bradycardia and hypotension (\~20 mmHg below fed state) were noted in juvenile pigs following 29 days of complete starvation.[@b8-ccrep-9-2016-067] The porcine heart contains several structural differences relative to the human, most related to bipedal vs. quadrupedal stance.[@b9-ccrep-9-2016-067] As frequent syncope was also noted in that our case study, it is plausible that dysregulated autonomic regulation of blood pressure underlies the observed hypertension. Blood pressure was measured in a supine position, increasing venous return in the human relative to standing position. Simple Frank--Starling mechanics combined with a failure of autonomic regulation may thus explain elevated blood pressure. Thus, it is tempting to suggest that differences observed may be species dependent; however, this is highly speculative on a single case study. Further, long-lasting cardiovascular deficits were noted in the above porcine model on refeeding, as well as chronically following experimental conclusion.[@b8-ccrep-9-2016-067] As death resulting from starvation often occurs via cardiovascular complications, this elevated blood pressure during fast is key to note; this should be carefully monitered in fasting individuals.

Caloric restriction and weight loss in overweight or obese individuals is often associated with subsequent regain of weight.[@b10-ccrep-9-2016-067],[@b11-ccrep-9-2016-067] Having access to this case study 30 days following resumption of feeding was of interest due to a chance to examine any occurrence of such a rebound effect. It is of interest to note that this was not seen here; however, future gains in weight cannot be ruled out.

Here, we report the maintenance of physical function of an individual after 49 days of complete fast. This report does not indicate support for such behavioral choices, and the projections of metabolic energy provision by starting adiposity assume no other perturbations to homeostasis, such as impaired immune response, liver and renal function, or cardiovascular events. Such a voluntary behavioral choice is difficult to support.

The authors thank Dr. Louise Thomas for discussions regarding modeling of survival during severe fasting.

**ACADEMIC EDITOR:** Athavale Nandkishor, Associate Editor

**PEER REVIEW:** Four peer reviewers contributed to the peer review report. Reviewers' reports totaled 1,224 words, excluding any confidential comments to the academic editor.

**FUNDING:** BE is supported by the Society for Endocrinology (UK). The authors confirm that the funder had no influence over the study design, content of the article, or selection of this journal.

**COMPETING INTERESTS:** Authors disclose no potential conflicts of interest.

Paper subject to independent expert blind peer review. All editorial decisions made by independent academic editor. Upon submission manuscript was subject to anti-plagiarism scanning. Prior to publication all authors have given signed confirmation of agreement to article publication and compliance with all applicable ethical and legal requirements, including the accuracy of author and contributor information, disclosure of competing interests and funding sources, compliance with ethical requirements relating to human and animal study participants, and compliance with any copyright requirements of third parties. This journal is a member of the Committee on Publication Ethics (COPE).

**Author Contributions**

Conceived and designed the experiments: BE. Analyzed the data: BE. Wrote the first draft of the manuscript: BE. Contributed to the writing of the manuscript: BE, MM, CF. Agreed with manuscript results and conclusions: BE, MM, CF. Jointly developed the structure and arguments for the paper: BE, CF. Made critical revisions and approved the final version: BE. All the authors reviewed and approved the final manuscript.

![One-year history of body mass.\
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###### 

Serum biochemical values at day 49 of fast and 28 days post cessation of fasting.

                               DAY 49 OF FAST                                             28 DAYS POST RESUMPTION                                    UNITS
  ---------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ------------
  Albumin                      49                                                         44                                                         g·L^−1^
  Alkaline phosphatase         **36[\*](#tfn1-ccrep-9-2016-067){ref-type="table-fn"}**    42                                                         U·L^−1^
  Alanine aminotransferase     34                                                         19                                                         U·L^−1^
  Aspartate aminotransferase   33                                                         23                                                         U·L^−1^
  Calcium                      2·40                                                       2·30                                                       mmol·L^−1^
  Adjusted calcium             2·22                                                       2·22                                                       mmol·L^−1^
  Cholesterol                  **3·4[\*](#tfn1-ccrep-9-2016-067){ref-type="table-fn"}**   3·7                                                        mmol·L^−1^
  Creatinine                   90                                                         80                                                         µmol·L^−1^
  Gamma-glutamyl transferase   24                                                         27                                                         U·L^−1^
  Glucose                      **3·1[\*](#tfn1-ccrep-9-2016-067){ref-type="table-fn"}**   4·0                                                        mmol·L^−1^
  HDL-cholesterol              1·50                                                       1·37                                                       mmol·L^−1^
  LDL-cholesterol              2·0                                                        2·1                                                        mmol·L^−1^
  Phosphate                    1·3                                                        1·1                                                        mmol·L^−1^
  Potassium                    4·6                                                        4·6                                                        mmol·L^−1^
  Sodium                       142                                                        148                                                        mmol·L^−1^
  Total bilirubin              19                                                         18                                                         µmol·L^−1^
  Direct bilirubin             **7·0[\*](#tfn1-ccrep-9-2016-067){ref-type="table-fn"}**   **4⋅6[\*](#tfn1-ccrep-9-2016-067){ref-type="table-fn"}**   µmol·L^−1^
  Total protein                73                                                         71                                                         g·L^−1^
  Triglycerides                0·8                                                        0·5                                                        mmol·L^−1^
  Urea                         2·3                                                        3·4                                                        mmol·L^−1^
  Uric acid                    **620[\*](#tfn1-ccrep-9-2016-067){ref-type="table-fn"}**   355                                                        µmol·L^−1^

**Note:**

Values outside normal range for age and gender.[@b12-ccrep-9-2016-067]
